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Antibodies detected, in broad occurrence, in normal human sera are classified
as natural antibodies (1, 2) . As the technology has progressed, an ever-increasing
number of such antibodies have been detected (3-14) . In many instances, the
antigenic sites recognized by thoseantibodies have been identified ascomponents
of autogenous molecules and, thus, the designation "autoantibodies" has been
applied and various immunoregulatory or housekeeping functions have been
assigned . A long-held hypothesis has recently been restated and supporting
evidence presented that the molecules with which certain natural antibodies are
antigenically reactive may provide the immunogenic stimulus for their induction
or expansion (6) .
We report here the identification of a specific set of IgM antibodies that are
present in all sera from a representative population of normal individuals, thus
fulfilling the criterion of natural antibodies . However, since those antibodies are
present in sera of individuals whose stage of development assures that they have
not been exposed to the self-proteins with which the antibodies are antigenically
reactive, that hypothesis of origin may not apply and the designation "autoanti-
bodies" may not be appropriate .
We have detected antibodies of the IgG class reactive with purified protamines
of human sperm in all sera of 140 normal subjects including neonatal, pediatric,
and adult males and females . Similarly reactive IgM antibodies were detected in
all except the neonatal sera (Table I) .
Protamines are small highly basic nucleoproteins that occur in no cells other
than spermatids and spermatozoa . Those proteins are synthesized de novo and
incorporated into the nuclei of spermatogenic cells during spermiogenesis, a
progression that takes place in the immunologically sequestered lumena of the
seminiferous tubules of the postpuberal testis (15) . Although that structural
immunologic barrier does not continue into the excurrent ducts of the male
tract, there is evidence that immunosuppressive substances are introduced as the
semen is formed, and under normal conditions, immunity to sperm-unique
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components may be inhibited (16). Similarly, it is logical to accept the premise
that immunosuppressive factors may be present in the female genital tract to
protect against the potential immunogenicity of components of the ejaculate
(17).
In the context ofthe foregoing, therefore, it seemsunlikely that the protamine-
reactive antibodies in all of the normal sera examined are attributable to
induction byprotamines. Moreover, even ifit ispossible that protamines, released
from degenerating sperm, may escape surveillance and suppression and, there-
fore, protamine-induced antibodies could be present in the sera of postpuberal
males and sexually experienced females while the protamine-reactive IgG in the
early pediatric sera could be attributed to placentally transferred maternal IgG,
it is clear that the protamine-reactive IgM antibodies in pediatric sera may not,
in any way, be attributable to induction by protamines. Commonality between
the protamine-reactive IgM antibodies of adult and pediatric sera is established
in this report. It appears, therefore, that protamines are not the immunogenic
stimulant for those antibodies. The questions then arise as to whether those
antibodies are induced by other autogenous proteins that are homologous with
protamines or arise by some not yet recognized immunologic mechanism and
whether the antigenic targets ofthat set ofnatural antibodies are protamines or
other molecules.
As the first address to those questions, with the aid of a mouse monoclonal
antibody (mAb) raised to human sperm protamines, we have characterized the
antigenic site recognized by the protamine-reactive IgM antibodies of human
sera.
Materials and Methods
ELISA.
￿
The assay method by which the data of Table I were assembled and which
was used throughout this study has been described (18, 19). Briefly, 50 j1 of antigen
(specified concentration) was placed in each well of a 96-well flat-bottomed microtiter
plate, covered, and held at room temperature for 4 h. The wells were washed (20x) with
0.01% Tween-20/PBS, then filled to the rim with 5% BSA, covered and held at 5'C
overnight. The plates were brought to room temperature and washed 20x and 50 ul of
serum or mAb (diluted with 1 % BSA) was added to each well. After 2 h at room
temperature, the wells were washed 20x and 50 ul of peroxidase-conjugated second
antibody [goat F(ab')2anti-human IgM 1 chain specific, or goat F(ab')2 anti-mouse IgA,
IgG, and IgM] was added. The plates were covered, held at room temperature for 1 .5 h,
and washed 20x. 50 ul of substrate (ortho-phenylene diamine) was added to each well
and, after 30 min, the reaction was stopped by the addition of 50 ul of H2SO4 (2.5 N).
The optical density of the colored solution in each well was read at 490 nm in an
automated plate reader. That protocol was developed to maximize sensitivity and to
minimize ambiguity arising from serum background and plate-to-plate differences in
binding efficiency (19). The total IgM and IgG titers of each serum were derived in
reference to a single standard serum for which the absolute weights of IgM and IgG were
determined.
Antigens.
￿
Purified protamine 1 (P1)' and protamine 2 (P2) were prepared as described
(20) with modifications. Briefly, spermatozoa were isolated from pooled ejaculates and
sonicated to separate heads from tails. The heads were collected and, by treatment with
Triton-X, were separated into a membrane protein fraction and a DNA-nucleoprotein
'Abbreviations used in this paper.
￿
HPmAb, mAb to human sperm protamines; P1 and P2, purified
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fraction. The latter was solubilized in 4 M guanidinium chloride (GuCI), 1 % 2-ME and
treated with ethylene-imine to aminoethylate the cysteinyl residues of the protamines,
thereby preventing formation of S-S bonds, then dialyzed against 50 mM HCl and
chromatographed on a BioRex 70 column with stepwise elution by ascending concentra-
tions of GuCl. Pure P1 appears in the 23% eluate, Pure P2 (a and b) appears in the 27%
eluate, while a series of phosphorylated variants of P2 together with a portion of the P1
appear in an intermediate pool (25% eluate). The P1 and P2 (23 and 27% eluates) were
each dialyzed overnight against 50 mM HCl, followed by 2-3 h dialysis against PBS, pH
7.2, and the concentration of each was measured by a dye-binding assay (21). The
synthetic peptides were prepared by the Protein Sequencing Laboratory at The Rocke-
feller University by the method of Merrifield (22) and purified by reverse-phase HPLC.
Polyarginine (10,000-20,000 mol wt) was obtained from Chemical Dynamics Corp.
(Plainfield, NJ) and polylysine (15,000-30,000 mol wt) was from Sigma Chemical Co. (St.
Louis, MO).
Purified calf thymus histones and pure histone H3 were a gift from Dr. Richard Sterner
(The Rockeller University, New York, NY).
Monoclonal Antibodies.
￿
The mAb to human sperm protamines (HPmAb) was obtained
by immunization of a BALB/c mouse with the nuclear protein fraction of human sperm
and fusion of the spleen cellswith a nonsecreting mouse myeloma. In preparation for this
study the hybridoma culture was recloned by limiting dilution to assure monoclonality.
The HPmAb was isolated from ascites fluid by ammonium sulfate precipitation and
purified by dialysis against PBS followed by DEAE column chromatography.
The mAb against chick myosin, used as control, was a gift from Dr. Anuradha Saad
(Cornell University Medical College, New York, NY) and was similarly prepared from
ascites fluid.
Human Sera. The sera were either donated by the authors and other laboratory
personnel or obtained as clinical specimens identified only with regard to date of birth,
sex, and "no findings."
Immunoabsorptions. For each of the immunoabsorption procedures the weight of
absorbing protein stated in the figure legend was coupled to 0.5 gm cyanogen bromide-
activated Sepharose 4B (Pharmacia Fine Chemicals, Piscataway, NJ) in an 0.7 x 10 cm
column. 40-50,u] serum, diluted 1 :50 with 1 % BSA/sodium borate buffer, pH 7 .5, was
layered on the column, which was then mixed end over end, overnight at 4°C . The
absorbed serum was drained out of the column and tested by ELISA at the noted dilutions
for reactivitywith the designated antigens.
Homology Search.
￿
A search for proteins bearing a six residue segment designated as
one with a minimum of four arginyl residues including a cluster of three was carried out
(9/11/87) by the Protein Identification Source of the National Biomedical Research
Foundation, and augmented by our own survey of the current literature.
Results
Occurrence ofProtamine-reactive Antibodies in Human Sera.
￿
The data of Table
I show that protamine-reactive antibodies are present in all sera of a cohort of
normal subjects aged 0-60 yr. Protamine-reactive IgG antibodies are present in
all sera and IgM antibodies are present in those whose immune systems have
matured sufficiently to produce a significant titer of IgM (23). A proportionality
of the total IgM represented by the protamine-reactive IgM was computed for
each serum of a group from each subject category (Fig. 1). We have not been
able, thus far, to isolate the protamine-reactive IgM antibodies from human sera,
with activity intact. The computation, therefore, does not designate the actual
weight of protamine-reactive IgM but does define the titer of protamine reactive
antibody, compared with the titer of total IgM, within a similar assay protocol.
The values derived for that proportionality, i.e., ratio of protamine-reactive IgMPediatric
7-28d I-12mo I-2yr
1.00
.80
60
40
.20
TABLE I
Occurrence ofHuman Serum Antibodies Reactive with
Human Sperm Protamines
Allsera were assayed at 1:100, 1:500, 1:1,000 with pooled humanprotam-
ines as antigen. All sera designated as positive displayedreactivity at 1:500
dilution. Titers of IgM andIgGreactivity with protamines were computed
relative to that of a reference serum (18, 19). Negative IgM values were
<1% of reference serum; positive IgM values for pediatric sera ranged
from 15% (7-d neonate) to 65%of referenceserum; IgGvalues were 40-
90% of referenceserum. Foradultsera, therange of IgM reactivity with
prolamine was 54-180% of reference serum and that of IgG reactivity
was 50-200%. Total IgG and IgM titers forall sera were within normal
range forthe respective age groups (23).
Adult
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same reference serum. Theplotted values are
x
for each
Y
serum.
FIGuRE 1.
￿
Proportionality of protamine-reactive IgM
to total IgM in human sera. Avalue (z) fortotal IgM for
each serum was derived as percentage of a reference
serum (see Materials and Methods) and a value (y) for
protamine-reactive IgM wasderived as percentage of the
to total IgM, for all population subgroups falls within a narrow range (Fig. I),
suggesting that the protamine-reactive antibodies represent a specific, and per-
haps obligatory, component ofthe natural antibody repertoire ofnormal human
serum.
Identification of Human Sperm Prolamines.
￿
The nuclear proteins of human
sperm include two protamines, designated P1 and P2. Determination of the
Age Number
tested IgM IgG
0 (cord blood) 1 0 1
1d 2 0 2
2d 2 0 2
4d 3 0 3
5d 2 0 2
7d 3 2 3
10d 3 2 3
12-28 d 11 11 11
1-12 mo 9 9 9
1-2 yr 4 4 4
adult6 41 41 41
adult 4 59 59 591232 PROTAMINE-REACTIVE NATURAL IgM ANTIBODIES IN HUMAN SERA
amino acid sequences has shown that P2 exists as two variants differing only in
that P2a has three additional residues at its NH2 terminus (Table IIA) (24, 25).
We have recently demonstrated that P1 and P2a,b are obtainable, in purified
form and in high yield, separately from a group ofphosphorylated variants of
P2 (26). Those preparations of P1 and P2 are in "ideal state" for use as antigen
in solid-phase assay since each is a small molecule with high positive charge
favoring linear orientation on the polystyrene surface and there is littlepossibility
of intramolecular crosslinkage since, in the preparative process, the cysteinyl
residues are amino-ethylated (see Materials and Methods), thus blocking forma-
tion ofdisulfide bonds.
Specificity ofHPmAbfor Protamines: Definition ofthe Epitope.
￿
We have prepared
an mAb (HPmAb), using the nucleoprotein fraction of human sperm as the
immunogen, that is reactive with P1 and P2 and the phosphorylated variants of
P2 and with no other component of human sperm (Fig. 2). Repeated assays,
using different batches ofpurified P1 and P2 have confirmed that, although the
reactivity with each is of the same order of magnitude, HPmAb displays greater
reactivity with P1 when assayed against molar equivalents of P1 and P2. Inspec-
tion of the primary structure of those molecules (Table IIA) reveals that there
is not extensive sequence homology between the two; positional homology at
four residues within a six residue piece is displayed in only three segments: 7-
12 of P1 with 20-25 ofP2b, 29-34 ofP1 with 34-39 of P2b, and 45-50 of P1
with 49-54 ofP2b. However, for each, P1 and P2b, arginine comprises 48% of
the amino acid composition, and, in each, a number of the arginyl residues are
clustered. Although a greater proportion ofthearginyl residues ofP2 is grouped
in clusters oftwo or more residues, P1 has a single cluster ofsix arginyl residues.
That inspection of the amino acid sequences suggested that recognition of the
protamines by HPmAb might be dependent uponarginine density. The HPmAb,
therefore, was assayed against three synthetic decapeptides (Table IIB) repre-
sentingsegmentsofP2 selected fordifferential density ofarginine and for variety
ofother amino acids, and against polyarginine, representing maximum arginine
density. The high reactivity of HPmAb with polyarginine (Table III A) supports
the proposition thatthe recognition is dependent upon clustered arginyl residues
and suggests that other amino acids are not essential for recognition of the
epitope. Peptide 1 shows no reactivity with HPmAb, suggesting that a cluster of
two arginyl residues is inadequate for recognition while the modest, but real,
reactivity ofpeptide 2 suggests that a density offour arginyl residues, including
a cluster of three, within a six residue piece is recognized (Table III A). The
apparent inconsistency of the display of reactivity by peptide 3 (Table IIIA), in
which the four arginyl residues are single, was readily resolved. When the
syntheticpeptides wereused assynthesized, i.e., nottreatedtoblockthe cysteine-
cysteine crosslinkage, peptide 3 showed reactivity with HPmAb. However, when
the three peptides were treated, as in the preparation of the protamines (see
Materials and Methods), to block the formation of S-S bonds between the
cysteinyl residues, the reactivity ofpeptide 3 with HPmAb was eliminated (Table
IIIB). We interpret that observation to indicate that, in the untreated state, the
two cysteinyl residues in peptide 3 are crosslinked, resulting in a conformation
in which the four single arginyl residues are brought intojuxtaposition so thatPROTAMINE-REACTIVE NATURAL IgM ANTIBODIES IN HUMAN SERA 1233
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HPmab reciprocal dilution
FIGURE 2 .
￿
(A) Fractions of human sperm proteins. (Lanes 1-5) SDS PAGE ; (lanes 6-8) ace-
tic acid-urea PAGE . (Lane 1) Mol wt markers, 14.4, 20, 30, 43, 67, 94 x 10' ; (lane 2)
tail proteins ; (lane 3) Triton-X soluble proteins of head membranes; (lane 4) 8% eluate of
BioRex-70 chromatogram of nuclear proteins ; (lane 5) 16% eluate ; (lane 6) 23% eluate (P1) ;
(lane 7) 25% eluate (P1 andphosphorylated P2) ; (lane 8) 27% eluate (P2) . (B)ELISA values of
HPmAb reactivity with each sperm protein fraction . (Lanes 2-5) . . . .; (lane 6)-- "-,
(lane 7)- ; (lane 8) -- . HPmAb is reactive only with the three protamine fractions (lanes
6, 7, and 8) .
those residues are in adequate proximity or orientation forantibody recognition
to take place . With the cysteinyl residues blocked, that conformation was not
induced and peptide 3 was not reactive with HPmAb (Table 111B) . Consonant
with that observation, the reactivity of peptide 2, putatively dependent upon a
density of four arginyl residues including a triplet, and the absence of reactivity
ofpeptide I were notaltered by treatment to block cysteine-cysteine crosslinkage
(Table IIIB) .
The specific requirement of the HPmAb for an epitope including an arginine
triplet was further documented when the HPmAb displayed no reactivity (data
not shown) against the more prevalent set of basic nuclear proteins, the histones
and, specifically, against the arginine-rich histone H3, in which there are two
arginine doublets, residues 52, 53 and 128, 129, but no arginine triplet (27) .
The possibility that recognition by HPmAb of a cluster of three or more
arginyl residues is due solely or mainly to a concentrated high positive charge
was probed further by comparing the reactivity of HPmAb with polyarginine,
representing maximal net positive charge as well as maximal arginine density,
with that of polylysine, representing very nearly as high net positive charge (Fig.
3) . The assay data of Fig . 3 indicate that the specificity of theHPmAb is not that
of recognition of an epitope with high positive charge but is related to unique1.00
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E 70
.50
.40
0
30
20
10
105
A
104
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TABLE III
Reactivity (OD49o) ofHPmabwith Synthetic Peptides
(Table II)and Polyarginine
A
￿
Peptide 1 (50)
￿
0.06
￿
0.06
Peptide 1 (10)
￿
0.00
￿
0.01
Peptide 2(50)
￿
0.33
￿
0.05
Peptide 2(10)
￿
0.27
￿
0.01
Peptide 3 (50)
￿
0.25
￿
0.05
￿
<0.04
Peptide3 (10)
￿
0.11
￿
0.01
￿
T
Polyarginine (20)
￿
0.82
￿
0.10
Polyarginine (10)
￿
0.80
￿
0.08
B
￿
Peptide 1 (50)
￿
0.06
￿
0.04
Peptide 2 (50)
￿
0.32
￿
0.03
Peptide 3 (50)
￿
0.05
￿
0.04
(A) Peptides untreated. (B) Peptides amino-ethylated to block formation
of S-S bonds between cysteinyl residues. (A) HPmab is reactive with
peptides 2,3 (untreated) and with polyarginine. (B) Amino-ethylation of
peptides results in elimination of reactivity of HPmabwith peptide 3 and
no change in reactivity of peptide 1 or 2. Control mab (anti-myosin) and
non-immunized mouseserumarenotreactive with thepeptides or polyar-
ginine.
Antigen (rag/ml)
B
105 103 104 105
HPmab reciprocal dilution
HP mab
1:1,000
Myosin
mab
1:1,000
Nonimmun
ized mouse
serum
1:100
FIGURE 3. Reactivity
￿
of
HPmAbwith (A)polyarginine
and(B)polylysineat ascending
antigen concentrations. 2 ug/
ml polyarginine (---" --);
5, 10, or 20 lag/ml polyar
ginine (. . . .); 2, 5,
￿
10 or 20
jig/ml polylysine (-). Each
plotted value represents the
mean of four assays, carried
outin duplicate.
properties inherent in a cluster of arginyl residues.
has not yet been determined.
Comparison of the reactivity curves (Figs. 3 and 4) indicates greater similarity
in the binding kinetics of HPmAb with P1 and polyarginine than with P 1 and
P2. For both P 1 and polyarginine, HPmAbappears to be saturated at low antigen
concentration. For polyarginine that might be postulated to be due to a higher
order of reiteration of the epitope, but in both P1 and P2 the putative minimum
epitope of six amino acids (28), in this instance a six amino acid piece with four
arginyl residues including a cluster of three, appears twice. The greater reactivity
of HPmAb with P1 (Fig. 4), therefore, may be due to the cluster of six arginyl
residues, a density of arginine not present in P2 (Table IIA).
The nature ofthose properties1236 PROTAMINE-REACTIVE NATURAL IgM ANTIBODIES IN HUMAN SERA
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FIGURE 4. Reactivity
￿
of
HPmAb with (A) P1 at 2
leg/ml (-.-.-.); 5 Fig/ml
( ); 10 or 20 fag/ml
(B) P2 at 2 ug/ml
------ ); 5 Ag/ml (. . . . )
10 ,Ag/ml (-); 20 u/ml
(-). See text fordiscussion.
Each plotted value represents
the mean of five assays, each
carried out in duplicate. With
molar equivalents (equivalent
weights) ofP1 andP2, reactiv-
ity of HPmAb is greater with
andsaturatedat lowerantigen
concentrations of P1 .
An overview of the foregoing data leads to the proposition that the HPmAb
reacts with clustered arginyl residues, with activity strength related to arginine
density, with a minimum requirement of four within a six residue epitope with
three of the arginyl residues in series or in juxtaposition to provide a specific
configuration of three arginyl residues; the precise geometry ofthat configura-
tion has not been defined.
Protamine-reactive Antibodies in Human Serum.
￿
The properties of the human
serum protamine-reactive IgM antibodies (Table 1) were investigated by compar-
isonwith thoseestablished forHPmAbandby determining whether the reactivity
resides in a specific subset of human IgM antibodies.
The relative reactivities of a representative group of human sera (adult male,
adult female, and pediatric) with P1 and P2 and polyarginine were assayed (Fig.
5). Despite the expected differences in absolute titer, the similarity among the
sera in rank order of activity with the three antigens, in the slopes of serum
dilution versus reactivity curves and in the response to increasing antigen
concentration suggests that the serum reactivity is that of a discrete set of IgM
antibodies present in all normal sera. The data of Fig. 5 also confirm that the
protamine-reactive IgM antibody set ofpediatric sera has the same properties as
that of adult sera.
Concordance between the immuno-recognition properties of the human IgM
antibodies and those of the HPmAb was demonstrated by competition ELISA
(Fig. 6). The inhibition by HPmAb of the serum antibody reactivity with both
P1 and P2 was proportionate to the concentration of HPmAb. Nearly 50%
inhibition of the serum reactivity with P1 was achieved by HPmAb dilution of
1:1,000. Consonant with the observation that the HPmAb displays greater
reactivity with P1 than with P2 (Figs. 2B and 4), the data of Fig. 6 also indicate
that the HPmAb displays greater competition with the P1 reactivity ofthe serum
antibodies than with the P2 reactivity.
Assurance that the blocking of the serum IgM reactivity with P1 and P2 was
due to specific epitope recognition by the HPmAb was provided by parallel
assays carried out with a mouse mAb to chick myosin and with normal (nonim-
munized) mouse serum, with no inhibition of human serum IgM reactivity with
P1 and P2 exhibited by either (data not shown).
The converse competition assay, i.e., blocking of the HPmAb with humanE
O
o)
v
0
O
500 1000 100
￿
500 1000 100
reciprocal human serum dilution
100 500
reciprocal serum dilution
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FIGURE 5.
￿
Reactivity of human
serum IgM with (A) P1, (B) P2,
(C) polyarginine at 2 ju/ml
5
￿
JAg/ml
￿
(. . . . . . .);
￿
10
Ag/ml (-); 20 tag/ml (---) of
each antigen. (Left panels) pediat
ric (6 mo) serum; (middle panels)
adultmale; (right panels) adultfe-
male.
FIGURE 6. Competition by HPmAb with
human serum IgM reactivity against (A) P1
and (B) P2. The standard ELISA protocol
(see Materialsand Methods) wascarried out
with the followingmodification: Before the
addition of human serum to the antigen-
bound wells, 50 gl HPmAb at dilution
1:1,000 (-),1:10,000 (. . ..), no HPmAb
(--) was placed in each well for 1 h, then
washed out and followed by human serum
in the noted dilutions; reactivity was de-
tected by use of peroxidase-conjugated
anti-human IgM. (A) HPmAb 1:1,000
blocked^-45% of serum reactivity, at 1:100
and 1:500 of serum, with P1 . (B) HPmAb
1:1,000 blocked ^-25% of serum reactivity
with P2 when the serum was 1:100 and
^-45% of reactivity when the serum was
1:500.
serum, also indicated that the epitope recognized by the HPmAb displays
homology with that recognized by the human protamine-reactive IgM antibodies
(Table IV). Although the maximum inhibition by human serum that was dis-
played in the solid-phase blocking assay used in this study was only ^-15% (Table
IV) similar blockingactivity was effected by a representative serum from each of1238 PROTAMINE-REACTIVE NATURAL IgM ANTIBODIES IN HUMAN SERA
TABLE IV
Competition by HumanSera (Adult (5, Adult Y, Pediatric) with
Reactivity ofHPmab against (A) PI (10 ug/ml) and (B)P2
(10 Ag/ml)
A
B
TheELISAprotocol (see Materials and Methods) wascarried outwith the
insertion of a single step: before addition of HPmab, 50 jut of human
serum was added to each well, and after 1 h (room temperature) was
removed and the wells were washed. The reactivity was detected by
peroxidase-conjugated anti-mouse IgA, IgG, IgM.
TABLE V
Reactivity (OD49o)ofHuman Sera IgM with SyntheticPeptides (Table II)(A)Peptides Untreated
(B) Peptides Amino Ethylated
A
B
Humanserum IgM antibodies are not significantly reactive with peptide 1 untreated or treated, are
reactive with peptide 2 when both untreatedandtreated, and arereactive with peptide 3 untreated,
butnot when the peptide is treated to prevent cysteine-cysteine crosslinkage (see Table III).
the human population classes, adult male, adult female, and pediatric. That
observation is in accord with the display of similar discrimination and activity of
adult and pediatric sera with the synthetic peptides used to define the epitope
for HPmAb (compare Tables III and V). The data of Table V, showing that the
reactivity of the serum antibodies with the synthetic peptides parallels that of the
HPmAb, also provide further support for the consideration that the epitopes for
the two categories of antibodies are similar. The IgM antibodies of all three sera
recognized, as did the HPmAb (Table III), peptide 2 in either ethylated or
nonethylated state (cysteine-cysteine crosslinkage blocked or unblocked), did not
Serum (1 :100)
HPmab
OD
1:1,000
Decrease
HPmab
OD
1:10,000
Decrease
0 0.79 - 0.74 -
Adult d 0.71 10 0.65 12
Adult 4 0.70 12 0.65 12
Pediatric 0.68 14 0.63 15
0 0.64 - 0.57 -
Adult d 0.61 - 0.53 -
Adult 9 0.62 - 0.51 11
Pediatric 0.58 10 0.51 11
Serum
Adultd Adult 9 Pediatric
1:100 1:500 1:100 1:500 1:100 1:500
Peptide 1 0.12 0.09 0.02 0 0.07 0.02
Peptide 2 0.72 0.24 0.70 0.29 0.63 0.19
Peptide 3 0.82 0.24 0.47 0.18 0.56 0.20
Peptide 1 0.06 0.02 ND ND ND ND
Peptide 2 0.78 0.24 ND ND ND ND
Peptide 3 0.05 0.01 ND ND ND ND80
60
40
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80 B
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FIGURE 7.
￿
Reactivity of human serum IgM with P1 (-); P2
(-), andspermhead membrane proteins (. . . .)afterabsorption of
serum on pooled protamines. (A) Nonabsorbed serum; (B) serum
absorbed on 100 wg of protamines; (C) serum absorbed on 200 rig
of protamines.
recognize peptide 1 in either state, and recognized peptide 3 when nonethylated,
but not when ethylated (Table V).
To assure that the serum reactivity with protamines is attributable to a
circumscribed set of IgM antibodies, a series of affinity absorption procedures
was carried out. First, it was demonstrated that those antibodies distinguish
between a fraction of pooled protamines and a fraction of sperm membrane
proteins which, as shown previously (29), includes eight or nine proteins that are
reactive with naturally occurring human serum antibodies. After absorption on
an affinity column to which ascending amounts of pooled protamines were
bound, the serum reactivity with protamines was progressively reduced to zero
while only minor reduction of serum reactivity with the membrane protein
fraction was observed (Fig. 7).
As in the analysis of the epitope for the HPmAb, the possibility was considered
that the reactivity of the serum antibodies was primarily that of a charge-
dependent reaction. Also, since autoantibodies to histones have been identified
in both normal and pathologic human sera (30) an assessment was made of the
ability of human serum IgM antibodies to discriminate between protamines and
histones. In affirmation of the high sensitivity of the ELISA method used in this1240 PROTAMINE-REACTIVE NATURAL IgM ANTIBODIES IN HUMAN SERA
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study (18, 19) a high titer of IgM antibodies reactive with purified calf thymus
histones was detected in the test serum (Fig. 8A). After absorption of an aliquot
of the serum on a histone bound affinity column, however, that reactivity was
eliminated while reactivity ofthe histone-absorbed serumagainst protamines was
virtually unchanged (Fig. 8, B and C).
Further assurance that the protamine reactivity ofa subset of IgM antibodies
in human serum is not that ofcharge attraction was obtained by the data of Fig.
9. When tested with polylysine, IgM antibodies ofhuman serum did bind to that
antigen. However, when the serum was absorbed on a polylysine-bound affinity
column, reactivity with polylysine was deleted while reactivity with protamines
and with polyarginine was retained (Fig. 9B). Conversely, when the serum was
absorbed on polyarginine, reactivity with polylysine was retained while reactivity
with protamine 1, protamine 2 and polyarginine was deleted (Fig. 9C) .
Antigenic Sites Recognized by HPmAb and Human Serum Ig Antibodies are Similar
(Perhaps Identical). Table VI is a summary comparison of the reactivity of
HPmAb, a mouse IgG secreted by a hybridoma of reasonably assured mono-
clonality (see Materials and Methods) and the reactivity of a specific subset ofE C
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TABLE VI
Summary ofConcordance ofAntigen Recognition by HPmab and
Protamine Reactive Serum IgMAntibodies
Antigen
HPmab
P1
￿
++
P2
￿
+
Polyarginine
￿
++
Polylysine
￿
-
Peptide I
￿
-
Peptide 1, ethylated
￿
-
Peptide 2
￿
+
Peptide 2, ethylated
￿
+
Peptide 3
￿
+
Peptide 3, ethylated
￿
-
PooledCTH
￿
-
Histone H3
￿
-
Sperm membrane proteins
￿
-
ELISA
FIGURE 9. Reactivity of human
serum IgM with PI P2
(---), polyarginine ( ), and
polylysine (------- ) . (A) Non-
absorbed serum ; (B)serum absorbed
on 200 tcg polylysine ; (C) serum ab-
sorbed on 200 jig polyarginine .
Total
serum
IgM
Protamine-
reactive
serum IgM
* Serum absorbed on polylysine : polylysine-reactive antibodies deleted,
protamine-reactive antibodies retained .
$ Serum absorbed on CTH: histone-reactive antibodies deleted, protam-
ine-reactive antibodies retained .
1 By inference from t.
w Serum absorbed on pooled protamine : protamine-reactive antibodies
deleted, sperm membrane protein-reactive antibodies retained.
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natural IgM antibodies in human sera . That comparison indicates that the
epitopes forthe two antibody setsshow a high degree ofhomology . Theprinciple
difference detected by the experimental protocolsof this study is that of apparent
rank order of reactivity with the three antigens, human sperm protamine 1,
human sperm protamine 2, and polyarginine (compare Figs . 3 and 4 with Fig.
5) . One possible explanation for that difference would be that the protamine-
reactive human IgM antibodies include several subsets with modestly different
preferences for intra-epitope arrangement of arginyl residues, or for extra-
epitope factors that influence binding patterns (28, 31) . It is apparent, however,1242 PROTAMINE-REACTIVE NATURAL IgM ANTIBODIES IN HUMAN SERA
that the dominant and common characteristic of the epitope recognized by both
HPmAb and serum IgM antibodies is that of clustered arginyl residues.
Since the protamine-reactive IgM antibodies are present in sera of individuals
who have had no exposure to sperm or protamines, the possibility was considered
that other proteins autogenous to humans with segments homologous to that
putative epitope might be related either to origin (immunogenic stimulation) or
to role (antigenic recognition) of that set of natural IgM antibodies. A search
was made of protein sequence data bases for segments of six amino acids with
four arginyl residues, including a cluster of three. That sequence was identified
in all of the vertebrate and invertebrate protamines or sperm-specific histories
that have been sequenced, in a few bacterial proteins mainly of E. coli, and in a
number of viral proteins (Table VII). The only human autogenous proteins
displaying that sequence, other than protamines, are two complement precursors,
two T cell glycoproteins and one (inferred) variant of the ti chain of class 11
histocompatibility antigens (Table VII).
Discussion
We have detected a set of natural IgM antibodies in sera of normal human
males and females of all age groups, that are reactive with human protamines,
the basic nuclear proteins of sperm, and we have identified the minimum
antigenic site of six residues as one with four arginyl residues including a cluster
of three. Since those antibodies are present in sera of pediatrics, who have had
no exposure to protamines, immunogenic stimulation by protamines as the origin
of those antibodies is argued against. Within the context of currently recognized
immunologic mechanisms, the origin of those antibodies, therefore, may be
attributed to other autogenous molecules with a sequence homologous with the
protamine antigenic site or to idiotopes on other Igs bearing the image of the
protamine antigenic site. Studies directed to the latter possibility are in prelimi-
nary status, hampered by the general difficulty of isolating specific subsets of
IgM antibodies from human sera (32) and the particular difficulty in isolating
the protamine-reactive antibodies with activity retained; those antibodies appear
to show very high binding strength to the conventional types of binding matrices
(our unpublished observations).
The possibility that those antibodies are induced by any of the segments of the
human proteins listed in Table VII is intriguing since all are believed to be
involved in immunoregulatory mechanisms and all may be present in the nascent
immune system. On the other hand, since the neonatal gastro-intestinal tract is
populated with E. coh, the possibility that the E. coli proteins (Table VII) provide
the initial stimulus for induction of the protamine-reactive antibodies also may
be considered and, in fact, a hypothesis of long-standing states that natural
antibodies may arise from stimulation by intestinal tract flora (2).
Perhaps even more provocative for consideration is the possible role of the
protamine-reactive antibodies, particularly in view of the limited spectrum of the
proteins listed in Table VII, many of which are of viruses with human host
specificity. The possibility that viral proteins may be the antigenic target of those
antibodies is reminiscent of an early hypothesis that one role of natural antibodies
may be that of defense against potential infectious agents (1).RODMAN ET AL.
TABLE VII
Proteins, Other than Protamines and Sperm-specific Histones, with a SegmentofSixAmino
Acids Including Four Arginyl Residues, Three ofwhich AreArranged in a Cluster
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Protein Residues
Human Complement C3 precursor 668-673
Complement C4A 1,426-1,431
Tcell surface glycoprotein CD8 precursor 208-213
Tcell surface glycoprotein CD4 precursor 422-427
Inferred precursor of ,y chain of histocom-
patibility antigen
Bacteria
Escherichia coli Replication initiation protein 57-62
65-70
Transposase 139-144
nusB protein 3-8
30 S ribosomalprotein 2-7
Alanyl-tRNA synthetase 430-435
Diaminopimelate decarboxylase 403-408
DNA-directed RNApolymerase 197-202
1,368-1,373
Serratia marcescens Anthranilate synthetase (component II) 157-163
Viruses
Herpes simplex (type 1) Kinase-related transforming protein 141-146
Herpes simplex(type 2) Glycoprotein D 364-369
Papillomavirus (type 6b) Probable L2 protein 4-9
Papillomavirus (type II) Probable L2 protein 3-8
438-443
Papillomavirus (type 33) Probable L2 protein 450-455
Probable E6 protein 140-145
Papillomavirus (type 8) Probable L2 protein 318-323
327-332
Hepatitis B virus (subtype AYW Core antigen 150-155
and 6 subtypes) 155-160
164-169
171-176
Epstein-Barr virus(strain B95-8) Hypothetical BHLF 1 protein 157-162
282-287
407-412
532-537
2,085-2,090
Hypothetical BORF 1 protein 9-14
Probable glycoprotein 528-533
837-842
Hypothetical BSLF 1 protein 859-864
Hypothetical BLLF 2 protein 53-58
Hypothetical BERF 3 protein 90-95
362-367
Hypothetical BRLF 1 protein 86-91
Adenovirus 2 Minor core protein 315-320
331-336
Probable early E4 34K protein 265-270
Probable earlyE4 13K protein 70-75
Probable early EIB 21K protein 157-1621244 PROTAMINE-REACTIVE NATURAL IgM ANTIBODIES IN HUMAN SERA
TABLE VII-Continued
HIV (HTLV III)
￿
Trans-activating transcriptional
regulatory protein: version 1
version 2
61-66
39-44
These studies have provided a definition of the antigenic site with which a set
ofnatural IgM antibodies ofhuman seraare reactive. Thus far, however, neither
the origin nor the role of that set ofantibodies is clear. The prevalence of those
antibodies in normal sera and the relatively high and constant proportion of the
total circulating IgM in which they are present suggest that such clarification
would be a significant contribution to the understanding of innate, in contrast
to induced, immunologic defense systems.
Summary
We have identified a set of natural IgM antibodies in human serum that are
reactive with protamines, a class of low molecular weight basic nucleoproteins
that are synthesized de novo in the postpuberal testis and are unique to sperm.
Those antibodies were detected by ELISA in significant titer in all of 100 sera
of normal adult males and females and in 26 of 28 sera of normal pediatrics
aged 7 d to 2 yr. Commonality between the protamine-reactive IgM antibodies
ofpediatric and adult sera was established by the demonstration of similarity in
antigen recognition and reaction kinetics. Therefore, the role of protamines as
either immunogenic stimulus or antigenic target ofthat set ofnatural antibodies
is not likely.
The antigenic site recognized by the protein-reactive serum IgM antibodies
was characterized by comparison with the pattern of antigen recognition by a
monoclonal antibody to human sperm protamines (HPmAb). By the use of
synthetic peptides simulating the amino acid sequences of various segments of
human protamine 2 and ofpolyarginine, polylysine, and histones as test antigens,
the principle characteristic ofthe antigenic site recognized by both HPmAb and
the serum IgM antibodies was inferred to be that of clustered arginyl residues
with an apparent minimum requirement of four arginyl residues, including a
Protein Residues
Late L1 52K protein 53-58
Early E2A DNA-binding protein 46-51
Majorcore protein precursor 100-105
152-157
Terminal protein 349-354
366-371
Adenovirus 5 Probable early EIB 21K protein 157-162
Late L1 52K protein 54-59
Early E2A DNA-bindingprotein 46-51
Adenovirus 7 Terminal protein 338-343
355-360
Rhinovirus 2 Genome polyprotein 1,396-1,401
Yellow fever virus(strain 17D) Genome polyprotein 1,702-1,707
Sindbis virus (two strains) Structural polyprotein 22-27
Nonstructural polyprotein 1,886-1,891
T cell leukemia virus (HTLV II) env polyprotein 305-310triplet, within a six residue piece ; for both, the reaction was shown to be not
dependent upon charge attraction . A series of immunoabsorption procedures
indicated that the protamine-reactive serum IgM antibodies are a discrete set
with a high order of specificity .
A search of protein data bases revealed that the putative minimum epitope is
present in four or five human autogenous proteins, all moieties of the immune
system, and in a number of viral proteins . The possible implications of those
findings are discussed in the light of early hypotheses concerning the origin and
function of natural antibodies and the many recent reports of identification of
natural antibodies in normal human sera . The set of natural antibodies identified
in this study may be unique or may represent a class of antibodies present in the
repertoire that, by virtue of the obscurity of their origin or function, have not
been previously or extensively recognized .
Receivedfor publication 20 October 1987 .
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